About
Dr. Wenger is Professor of Medicine in the Division of Cardiology at the Emory University School of Medicine. She is a Consultant to the Emory Heart and Vascular Center, and Founding Consultant, Emory Women’s Heart Center. Coronary heart disease in women is one of Dr. Wenger’s major clinical and research interests. She chaired the U.S. National Heart, Lung, and Blood Institute Conference on Cardiovascular Health and Disease in Women. Dr. Wenger has expertise in cardiac rehabilitation. She chaired the World Health Organization Expert Committee on Rehabilitation after Cardiovascular Disease, and co-chaired the Guideline Panel on Cardiac Rehabilitation for the U.S. Agency for Health Care Policy and Research. Dr. Wenger has a longstanding interest in geriatric cardiology, is Past President of the Society of Geriatric Cardiology and was Editor-in-Chief of the American Journal of Geriatric Cardiology for over 15 years. Dr. Wenger received the Outstanding Professional Achievement Award from Hunter College (1993), the Physician of the Year Award of the American Heart Association (1998), and the Distinguished Achievement Award from the Scientific Councils of the American Heart Association and its Women in Cardiology Mentoring Award (1999). In 2000, Dr Wenger was presented the James D. Bruce Memorial Award of the American College of Physicians for distinguished contributions in preventive medicine (2000). In 2002 she received the Distinguished Fellow Award of the Society of Geriatric Cardiology, and was included in the National Library of Medicine Exhibition Changing the Face of Medicine: A History of American Women Physicians (2003). Dr. Wenger received the Gold Heart Award, the highest award of the American Heart Association (2004). At the Emory University 2004 Commencement, Dr. Wenger received the Emory Williams Distinguished Teaching Award of the University and the Evangeline Papageorge Alumni Teaching Award of the School of Medicine. Dr. Wenger was selected to deliver the 2004 Laennec Lecture of the American Heart Association. In 2006, Dr. Wenger received the Hatter Award, international recognition for the advancement of cardiovascular science. The Georgia Chapter, American College of Cardiology, presented Dr. Wenger its Lifetime Achievement Award in 2009. She was selected Georgia Woman of the Year for 2010. In 2011, Dr. Wenger was selected to deliver the James B. Herrick lecture by the American Heart Association for her outstanding achievement in clinical cardiology. She was elected a member of Emory’s 175 Historymakers during Emory’s first 175 years. In 2012, Dr. Wenger received the Charles R. Hatcher, Jr., MD, Award for Excellence in Public Health from Emory University; and was honored in 2013 by establishment of the J. Willis Hurst, R. Bruce Logue, and Nanette K. Wenger Cardiovascular Society for Emory Cardiology Trainee Alumni. In 2013, she received the Inaugural Distinguished Mentor Award of the American College of Cardiology and the Arnall Patz Lifetime Achievement Award of the Emory School of Medicine Medical Alumni Association. The American Society of Preventive Cardiology honored Dr. Wenger by naming an annual Nanette K. Wenger Distinguished Lecture focusing on cardiovascular prevention in women (2014). In 2015, she was awarded the Inaugural Bernadine Healy Leadership in Women’s CV Disease Award, American College of Cardiology. Dr. Wenger received the Spirit of the Heart Legacy Award of the Association of Black Cardiologists (2017), and was an invited lecturer for the 70th Anniversary NHLBI program in Bethesda, MD (2018). In 2019 she received the Outstanding Alumna Award from the Emory Alumni Association, and in 2020 the American Heart Association’s Eugene Braunwald Academic Mentoring Award.. In 2021, the American Heart Association established the annual Dr. Nanette K. Wenger Award for the best scientific publication in cardiovascular disease in women.. The American College of Cardiology conferred its Lifetime Achievement Award on Dr. Wenger in 2022. She also received a Lifetime Achievement Award from the World Heart Federation. Dr. Wenger has participated as author of several American College of Cardiology/American Heart Association Clinical Practice Guidelines. She is past Chair, Board of Directors, Society for Women’s Health Research. Dr. Wenger serves on editorial boards of numerous professional journals and is a sought after lecturer for issues related to heart disease in women, heart disease in the elderly, cardiac rehabilitation, coronary prevention, and contemporary cardiac care. She is listed in Best Doctors in America.
View More >>Skills
Experience
Publication
-
December, 2019
Sex and Race/Ethnicity Differences in Atrial Fibrillation
Atrial fibrillation (AF), a worldwide epidemic, contributes to frequent hospitalizations, stroke, heart failure, disability, mortality, and health-resource consumption (1). AF affects people...
-
December, 2019
Sex and Race/Ethnicity Differences in Atrial Fibrillation
Atrial fibrillation (AF), a worldwide epidemic, contributes to frequent hospitalizations, stroke, heart failure, disability, mortality, and health-resource consumption (1). AF affects people...
-
September, 2019
Sex Differences in Cardiovascular Disease and Cognitive Impairment: Another Health Disparity for Women?
Although the number of Americans dying of cardiovascular disease (CVD) continues to increase since 2010 after decades of decrease, advances in the management of CVD have led to increased lon...
-
July, 2017
Quality and Equitable Health Care Gaps for Women: Attributions to Sex Differences in Cardiovascular Medicine
The present review synthesizes evidence and discusses issues related to health care quality and equity for women, including minority population subgroups. The principle of “sameness” or ...
-
October, 2016
Women, Hypertension, and the Systolic Blood Pressure Intervention Trial
Hypertension accounts for approximately 1 in 5 deaths in American women and is the major contributor to many comorbid conditions. Although blood pressure lowering reduces cardiovascular dise...
-
April, 2016
Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease
Declines in cardiovascular deaths have been dramatic for men but occur significantly less in women. Among patients with symptomatic ischemic heart disease (IHD), women experience relatively ...
-
February, 2016
Focused Cardiovascular Care for Women
Journal : Mayo Clinic Proceedings 1942-5546
Over the past decade, an emerging clinical research focus on cardiovascular (CV) disease (CVD) risk in women has highlighted sex-specific factors that are uniquely important in the preventio...
-
November, 2014
Effects of Sex and Gender on Adaptation to Space: Cardiovascular Alterations
Sex and gender differences in the cardiovascular adaptation to spaceflight were examined with the goal of optimizing the health and safety of male and female astronauts at the forefront of s...
-
January, 2013
Maternal Recall of Hypertensive Disorders in Pregnancy: A Systematic Review
Background: Hypertensive disorders in pregnancy are risk markers for future maternal coronary heart disease (CHD). Clinical assessment of a woman's history of pregnancy complications relies ...
-
September, 2011
Comparative Effectiveness of Exercise Electrocardiography With or Without Myocardial Perfusion Single Photon Emission Computed Tomography in Women Wit...
Background— There is a paucity of randomized trials regarding diagnostic testing in women with suspected coronary artery disease (CAD). It remains unclear whether the addition of myocardi...
Scholar9 Profile ID
S9-012025-1708493

Publication
(12)

Article Reviewed
(0)

Citations
(6795)

Network
(10)

Conferences/Seminar
(0)